Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

13 Canadian Crypto ETFs (Updated 2024)

When is the Starlink IPO Date and Can You Invest? (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

How Could Trump's US Election Win Affect the Gold Price?

Top 4 Largest Lithium Reserves by Country (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Trending Press Releases

Osisko Metals Announces Significant Increase in Mineral Resources at Gaspé Copper

Bitcoin Well Provides Update to the Bitcoin Super Company Vision and Bitcoin Reserve Fund

Silver47 Drills 2.48m of 14.95 g/t Gold, 249.50 g/t Silver, 21.97% Zinc, 7.03% Lead, 0.42% Copper at Its Red Mountain Project, Alaska

OSISKO METALS EXPANDS LEADERSHIP TEAM AND ANNOUNCES C$100 MILLION BOUGHT DEAL FINANCING

Ashburton Drilling Programme Delivers Further Significant Uranium Intersections

Altech Batteries Limited (ASX: ATC) – Trading Halt

More Press Releases
Trending Companies

Purpose Bitcoin ETF

BTCC:CA

Silver47 Exploration

AGA:CC

Syntheia

SYAI:CC

CI Galaxy Bitcoin ETF

BTCX.B:CA
More Companies
Trending Reports

2024 Lithium Market Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Gold Outlook Report

2024 AI Market Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Fennec Pharmaceuticals Inc.

TSX:FRX
Press Releases

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.

Interactive Chart

×